Agilent Technologies, Inc. rose 2.65% in intraday trading. The company's stock price increase may be attributed to the appointment of Brian O'Sullivan as Head of Commercial for Ginkgo Automation, a subsidiary of Ginkgo Bioworks. This strategic move is expected to enhance Ginkgo Automation's commercial efforts, including sales, business development, and customer success, which could positively impact the company's revenue and market position.
Comments
No comments yet